Journal Article
. 2020 Jul; 6:27.
doi: 10.1038/s41523-020-0169-8.

Histopathologic, immunophenotypic, and proteomics characteristics of low-grade phyllodes tumor and fibroadenoma: more similarities than differences

Lingxin Zhang 1 Chen Yang 1 John D Pfeifer 1 Richard M Caprioli 2 Audra M Judd 2 Nathan H Patterson 2 Michelle L Reyzer 2 Jeremy L Norris 2 Horacio M Maluf 1 
Affiliations
  • PMID: 32613078
  •     35 References

Abstract

Distinguishing low-grade phyllodes tumor from fibroadenoma is practically challenging due to their overlapping histologic features. However, the final interpretation is essential to surgeons, who base their management on the final pathology report. Patients who receive a diagnosis of fibroadenoma might not undergo any additional intervention while lumpectomy with wide margins is the standard of care for phyllodes tumor, which can have significant cosmetic consequences. We studied the clinical, immunophenotypic, and proteomics profiles of 31 histologically confirmed low-grade phyllodes tumor and 30 fibroadenomas. Matrix-assisted laser desorption ionization (MALDI) imaging mass spectrometry (IMS) and immunohistochemistry for Ki-67, p53, β-catenin, and E-cadherin were performed on all cases. After the mass spectra for all 31 cases of low-grade phyllodes tumor and 30 cases of fibroadenoma were collected, an average peak value for all cases was generated. There was no significant difference in the overall mass spectra pattern in any of the peaks identified. There was also overlap in the percentage of cells staining positive for Ki-67, p53, β-catenin, and E-cadherin. The two groups of patients showed no statistically significant difference in age, tumor size, or disease-free survival. Neither group developed malignant transformation, distant metastases, or disease-related mortality. We have demonstrated low-grade phyllodes tumor and fibroadenoma to show significant overlapping clinical and proteomics features.

Keywords: Breast cancer; Outcomes research; Surgical oncology.

Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
E K Millar, J Beretov, +4 authors, C S Lee.
Histopathology, 1999 Jun 26; 34(6). PMID: 10383692
Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas.
Rossitza Lazova, Erin H Seeley, +2 authors, Richard M Caprioli.
Am J Dermatopathol, 2011 Dec 27; 34(1). PMID: 22197864    Free PMC article.
β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Magali Lacroix-Triki, Felipe C Geyer, +4 authors, Jorge S Reis-Filho.
Mod Pathol, 2010 Aug 10; 23(11). PMID: 20693983
Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
Nicole Pfarr, Mark Kriegsmann, +10 authors, Albrecht Stenzinger.
Genes Chromosomes Cancer, 2015 May 02; 54(7). PMID: 25931199
Involvement of α- and β-catenins and E-cadherin in the development of mammary phyllodes tumours.
Julia Y S Tsang, Paulo Mendoza, +7 authors, Gary M Tse.
Histopathology, 2012 May 11; 61(4). PMID: 22571452
Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing.
Chieko Mishima, Naofumi Kagara, +6 authors, Shinzaburo Noguchi.
Breast Cancer Res Treat, 2015 Jun 22; 152(2). PMID: 26093648
Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Thomas J Lawton, Geza Acs, +8 authors, Carol Reynolds.
Int J Surg Pathol, 2014 Aug 28; 22(8). PMID: 25161205    Free PMC article.
Pathology interface for the molecular analysis of tissue by mass spectrometry.
Jeremy L Norris, Tina Tsui, Danielle B Gutierrez, Richard M Caprioli.
J Pathol Inform, 2016 May 04; 7. PMID: 27141319    Free PMC article.
E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Julia Y S Tsang, Paulo Mendoza, +5 authors, Gary M Tse.
Hum Pathol, 2012 Jul 24; 43(12). PMID: 22820000
Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
Kan Yonemori, Tadashi Hasegawa, +6 authors, Yasuhiro Fujiwara.
Pathol Res Pract, 2006 Aug 08; 202(10). PMID: 16889904
Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
Hui Wang, Xiang Wang, Cheng-Feng Wang.
Asian Pac J Cancer Prev, 2015 Jan 22; 15(24). PMID: 25605178
Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade.
Nara Yoon, Go Eun Bae, +10 authors, Eun Yoon Cho.
Genes Chromosomes Cancer, 2016 Feb 10; 55(6). PMID: 26856273
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways.
Fresia Pareja, Felipe C Geyer, +9 authors, Jorge S Reis-Filho.
NPJ Breast Cancer, 2017 Oct 19; 3. PMID: 29043292    Free PMC article.
Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma.
Weng Khong Lim, Choon Kiat Ong, +19 authors, Bin Tean Teh.
Nat Genet, 2014 Jul 21; 46(8). PMID: 25038752
Highly Cited.
MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases.
Cedric Chuan Young Ng, Jing Tan, +11 authors, Puay Hoon Tan.
J Clin Pathol, 2015 May 29; 68(9). PMID: 26018969
Phyllodes tumors.
M D Rowell, R R Perry, J G Hsiu, S C Barranco.
Am J Surg, 1993 Mar 01; 165(3). PMID: 8383473
Automated acoustic matrix deposition for MALDI sample preparation.
Hans-Rudolf Aerni, Dale S Cornett, Richard M Caprioli.
Anal Chem, 2006 Feb 02; 78(3). PMID: 16448057
Discerning the Primary Carcinoma in Malignant Peritoneal and Pleural Effusions Using Imaging Mass Spectrometry-A Feasibility Study.
Kristina Schwamborn, Gregor Weirich, +4 authors, Richard M Caprioli.
Proteomics Clin Appl, 2018 Oct 13; 13(1). PMID: 30311431
Phyllodes tumours of the breast: a consensus review.
Benjamin Y Tan, Geza Acs, +22 authors, Puay Hoon Tan.
Histopathology, 2016 Jan 16; 68(1). PMID: 26768026    Free PMC article.
Review.
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins.
Puay Hoon Tan, Aye Aye Thike, +6 authors, Phyllodes Tumour Network Singapore.
J Clin Pathol, 2011 Nov 04; 65(1). PMID: 22049216
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.
Andi K Cani, Daniel H Hovelson, +14 authors, Scott A Tomlins.
Mol Cancer Res, 2015 Jan 17; 13(4). PMID: 25593300    Free PMC article.
Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast.
Maria Helena Tavares Vilela, Fábio Marques de Almeida, +4 authors, Marise Amaral Rebouças Moreira.
Int J Surg Pathol, 2014 Feb 05; 22(6). PMID: 24492332
MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.
Salvatore Piscuoglio, Melissa Murray, +8 authors, Jorge S Reis-Filho.
Histopathology, 2015 Apr 10; 67(5). PMID: 25855048    Free PMC article.
A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer.
Dale S Cornett, James A Mobley, +4 authors, Richard M Caprioli.
Mol Cell Proteomics, 2006 Jul 20; 5(10). PMID: 16849436
MALDIquant: a versatile R package for the analysis of mass spectrometry data.
Sebastian Gibb, Korbinian Strimmer.
Bioinformatics, 2012 Jul 17; 28(17). PMID: 22796955
Highly Cited.
Protein identification strategies in MALDI imaging mass spectrometry: a brief review.
Daniel J Ryan, Jeffrey M Spraggins, Richard M Caprioli.
Curr Opin Chem Biol, 2018 Nov 27; 48. PMID: 30476689    Free PMC article.
Review.
Phyllodes tumors of the breast: natural history, diagnosis, and treatment.
Melinda L Telli, Kathleen C Horst, +2 authors, Robert W Carlson.
J Natl Compr Canc Netw, 2007 Apr 19; 5(3). PMID: 17439760
Review.
Phyllodes tumor of the breast.
Yazid Belkacémi, Guilhem Bousquet, +13 authors, Mahmut Ozsahin.
Int J Radiat Oncol Biol Phys, 2007 Oct 13; 70(2). PMID: 17931796
MED12 exon 2 mutations in phyllodes tumors of the breast.
Satoi Nagasawa, Ichiro Maeda, +5 authors, Tomohiko Ohta.
Cancer Med, 2015 Apr 14; 4(7). PMID: 25865354    Free PMC article.
Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
Benjamin F Dessauvagie, Andrew H S Lee, +8 authors, Rebecca Millican-Slater.
J Clin Pathol, 2018 Feb 15; 71(8). PMID: 29440134
Frequent MED12 mutations in phyllodes tumours of the breast.
M Yoshida, S Sekine, +5 authors, A Ochiai.
Br J Cancer, 2015 Apr 04; 112(10). PMID: 25839987    Free PMC article.
A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
Ashley Cimino-Mathews, Jessica L Hicks, +5 authors, Pedram Argani.
Hum Pathol, 2013 Aug 07; 44(11). PMID: 23916291    Free PMC article.
Genomic landscapes of breast fibroepithelial tumors.
Jing Tan, Choon Kiat Ong, +37 authors, Bin Tean Teh.
Nat Genet, 2015 Oct 06; 47(11). PMID: 26437033
A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Wai Jin Tan, Igor Cima, +5 authors, Puay Hoon Tan.
Breast Cancer Res, 2016 Mar 11; 18(1). PMID: 26961242    Free PMC article.
Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
Nicole Nicosia Esposito, Deepak Mohan, +3 authors, David J Dabbs.
Arch Pathol Lab Med, 2006 Nov 09; 130(10). PMID: 17090194